Clinical trial · Observational
Metabolomic Pathways and Traditional Chinese Medicine Body Constitution in Cancer-related Fatigue
The Exploration of the Relationship Between Metabolomic Pathways and Traditional Chinese Medicine Body Constitution in Cancer-related Fatigue in Patients With Colorectal Cancer
NCT07489833CI-TRIAL-00106508not yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to integrate insights from metabolomics and TCMBC to identify biomarkers and physiological pathways associated with CRF.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Self-report Questionnaire
- timeFrame
- Change from baseline to 3 months after surgery.
- description
- The study utilizes two instruments. First, the Fatigue Symptom Inventory (FSI) is used to assess fatigue; total scores range from 0 to 127, with higher scores indicating greater fatigue severity. Second, the Body Constitution Questionnaire (BCQ) comprises 16 items, with total scores ranging from 16 to 80.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients aged 18 years or older * Diagnosed with stage I to III CRC and scheduled for surgical treatment * Cognitively intact and able to communicate in either Mandarin or Taiwanese * Willing to participate in the study and provide written informed consent. Exclusion Criteria: * Patients diagnosed with stage IV colorectal cancer * Patients with recurrent colorectal cancer or other concurrent cancers.
References
Publications (0)
Data not yet available
No reference posted for this study.